Phase I–II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: A regimen with a low subjective toxic burden-Reference-Cited by-同舟云学术

Phase I–II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: A regimen with a low subjective toxic burden

Published:1997-08 Issue:9 Volume:8 Page:865-870
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Nolè F.,de Braud F.,Aapro M.,Minchella I.,De Pas M.,Zampino M.G.,Monti S.,Andreoni G.,Goldhirsch A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/9/865/19481189/8-9-865.pdf

Reference33 articles.

1. Treatment of metastatic disease;Flamm Honig,1996

2. Taxol: The first of taxanes, an important new class of antitumor agents;Rovinsky;Semin Oncol,1992

3. Experimental antitumor activity of 5’-nor-anhydro-vinblastine (Navelbine);Maral;Cancer Lett,1984

4. Experimental antitumor activity of Navelbine;Cros;Semin Oncol,1989

5. Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog;Ashizawa,1993

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the therapeutic potential of drug combinations through synergy prediction using graph transformer networks;Computers in Biology and Medicine;2024-03

2. Pharmacologic modulation of 5-fluorouracil by folinic acid and pyridoxine for treatment of patients with advanced breast carcinoma;Scientific Reports;2022-05-31

3. Combination of oral vinorelbine and capecitabine in the treatment of metastatic breast cancer patients previously exposed to anthracyclines: a pilot study;Hematology/Oncology and Stem Cell Therapy;2010-10

4. Capecitabine and vinorelbine in metastatic breast cancer;European Journal of Cancer;2009-09

5. A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines;Journal of Cancer Research and Clinical Oncology;2009-08-12